{"id":"W2049161486","doi":"10.1111/j.1464-410x.2008.08183.x","title":"The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":614,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surrey Memorial Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Urology; Testosterone (patch); Androgen deprivation therapy; Hormone antagonist; Clinical endpoint; Randomized controlled trial; Population; Prostate; Dosing; Prostate-specific antigen; Cancer; Internal medicine; Hormone; Endocrine system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007567839,0.0001323362,0.0009944133,0.00009332511,0.0001873947,0.00002685639,0.0001782056,0.00004535419,0.0000234979],"category_scores_gemma":[0.00008685319,0.00008115692,0.00004050221,0.0001476217,0.0006312709,0.0001347783,0.00008210012,0.0003887518,3.498517e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005591491,"about_ca_system_score_gemma":0.0002557913,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006447578,"about_ca_topic_score_gemma":0.001063965,"domain_scores_codex":[0.9980657,0.0004617117,0.0006872739,0.0001753674,0.0003308143,0.0002791084],"domain_scores_gemma":[0.99863,0.0003882652,0.0003933811,0.0001124135,0.0003424257,0.0001334544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8011584,0.004823462,0.175946,0.00001398231,0.0007029411,0.001283479,0.001810697,0.00003705348,0.00001216943,0.000004881203,0.0005466504,0.01366023],"study_design_scores_gemma":[0.6593872,0.0102631,0.3288372,0.000121401,0.0001617375,0.0004745362,0.0001742431,0.0000321898,0.000005327041,0.00001312391,0.0004629469,0.00006694581],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837391,0.01258367,0.00001363704,0.0004592784,0.0000635539,0.0029418,0.00001768808,0.000002776606,0.0001784915],"genre_scores_gemma":[0.9873484,0.01217641,0.0001030568,0.00007304133,0.00002896083,0.00008343114,0.000008723601,0.00001239934,0.0001655111],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1528912,"threshold_uncertainty_score":0.3309483,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03535916653170147,"score_gpt":0.3437018922021902,"score_spread":0.3083427256704888,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}